Acute Lymphoblastic Leukemia
European study confirms efficacy of clofarabine in pediatric patients with ALL
Published in Blood Weekly, January 12th, 2006
The update was given to a meeting of study investigators and European and Japanese hematologists.
Bioenvision reported a total of 37 patients have been enrolled to date in study BIOV-111, which is being conducted in 40 European centers (11 U.K.; 11 France; 9 Germany; 6 the Netherlands; 2 Italy; 1 Austria). Of the 20 evaluable patients, 5 (25%) have achieved, according to investigator assessment, a complete response (CR + CRp). "This is similar to the 20% complete...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-01-12)
More Articles from Blood Weekly
- Cord Blood
Unrelated cord blood transplant successful in children with Shwachman-Diamond syndrome - Liver Regeneration
Partial hepatectomy induces mobilization of stem cells in healthy liver donors - Stem Cell Research
Antibody-conjugated magnetoliposomes rapidly and efficiently expand mesenchymal stem cells - Tissue Engineering
Keratinocytes and dermal fibroblasts cultured on PLGA microspheres regenerates skin - Tissue Engineering
Pulsed low intensity ultrasound stimulates intervertebral disc cell cellular metabolism - Acute Myeloid Leukemia
Acute myeloid leukemia blasts regularly express PRR1 and PRR2 - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
